Avalon Globocare CORP. (ALBT) — SEC Filings

Overview

Avalon Globocare CORP. (ALBT) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a EFFECT filed on Apr 21, 2026: Avalon GloboCare Corp. filed an EFFECT form on April 21, 2026, indicating the effectiveness of a registration statement. The filing, with SEC Accession No. 9999999995-26-001253, relates to Act 33 and File No. 333-294936. The company's mailing and business address is 4400 ROUTE 9 SUITE 3100 FREEHOLD

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 4 bearish, 46 neutral. The dominant filing sentiment for Avalon Globocare CORP. is neutral.

Filing Type Overview

Avalon Globocare CORP. (ALBT) has filed 1 EFFECT, 1 424B3, 40 8-K, 5 10-Q, 1 8-K/A, 1 10-K, 1 DEF 14A with the SEC between Jul 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (50)

• Avalon GloboCare Corp. Filing Effectiveness Noticed — EFFECT · Apr 21, 2026 Risk: low
  Avalon GloboCare Corp. filed an EFFECT form on April 21, 2026, indicating the effectiveness of a registration statement. The filing, with SEC Accession No. 9999
• 424B3 Filing — 424B3 · Apr 20, 2026
• Avalon GloboCare Corp. Files 8-K Report — 8-K · Apr 1, 2026 Risk: low
  On April 1, 2026, Avalon GloboCare Corp. filed a Form 8-K to report other events and financial statements. The filing includes various documents related to thei
• Avalon GloboCare Corp. Files 8-K — 8-K · Dec 30, 2025 Risk: low
  Avalon GloboCare Corp. filed an 8-K on December 30, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, incorporat
• 8-K Filing — 8-K · Dec 15, 2025
• Avalon GloboCare Files 8-K — 8-K · Dec 1, 2025 Risk: low
  Avalon GloboCare Corp. filed an 8-K on December 1, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain
• 8-K Filing — 8-K · Nov 21, 2025
• Avalon GloboCare's Net Loss Widens to $16.2M Amid Debt Extinguishment — 10-Q · Nov 14, 2025 Risk: high
  Avalon GloboCare Corp. (ALBT) reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $16,194,977, a substantial rise
• Avalon GloboCare Corp. Files 8-K Report — 8-K · Sep 8, 2025 Risk: low
  On September 8, 2025, Avalon GloboCare Corp. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and includes Financial Statements and E
• Avalon GloboCare Corp. Files 8-K/A Amendment — 8-K/A · Aug 29, 2025 Risk: medium
  Avalon GloboCare Corp. filed an amendment (8-K/A) on August 29, 2025, to a previous report dated May 29, 2025. This amendment pertains to a material definitive
• Avalon GloboCare Corp. Files 8-K — 8-K · Aug 28, 2025 Risk: low
  Avalon GloboCare Corp. filed an 8-K on August 28, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain
• ALBT's Net Loss Soars to $15.9M Amid Debt Extinguishment, Cash Dwindles — 10-Q · Aug 14, 2025 Risk: high
  Avalon GloboCare Corp. (ALBT) reported a significant increase in net loss for the six months ended June 30, 2025, reaching $15,940,709, a substantial rise from
• Avalon GloboCare Reports Unregistered Equity Sales — 8-K · Aug 12, 2025 Risk: medium
  Avalon GloboCare Corp. filed an 8-K on August 12, 2025, reporting unregistered sales of equity securities that occurred on August 6, 2025. The filing does not s
• Avalon GloboCare Reports Unregistered Equity Sale — 8-K · Jul 30, 2025 Risk: medium
  Avalon GloboCare Corp. reported on July 17, 2025, an unregistered sale of equity securities. The filing does not specify the number of shares sold or the dollar
• Avalon GloboCare Corp. Files 8-K for Material Definitive Agreement — 8-K · Jul 29, 2025 Risk: medium
  On July 28, 2025, Avalon GloboCare Corp. entered into a material definitive agreement. The company, incorporated in Delaware with its principal executive office
• Avalon GloboCare Corp. Files 8-K Report — 8-K · Jul 28, 2025 Risk: low
  On July 28, 2025, Avalon GloboCare Corp. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No s
• Avalon GloboCare Corp. Files 8-K with Material Agreement — 8-K · Jul 23, 2025 Risk: medium
  On July 21, 2025, Avalon GloboCare Corp. entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The company
• Avalon GloboCare Corp. Files 8-K with Material Agreements — 8-K · Jul 18, 2025 Risk: medium
  On July 14, 2025, Avalon GloboCare Corp. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and
• Avalon GloboCare Corp. Files 8-K — 8-K · Jul 14, 2025 Risk: low
  On July 14, 2025, Avalon GloboCare Corp. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No s
• Avalon GloboCare Corp. Enters Material Agreement, Incurs Financial Obligation — 8-K · Jul 9, 2025 Risk: medium
  On July 3, 2025, Avalon GloboCare Corp. entered into a material definitive agreement. This filing also indicates the creation of a direct financial obligation o
• Avalon GloboCare Corp. Files 8-K with Material Agreement — 8-K · Jun 26, 2025 Risk: medium
  On June 23, 2025, Avalon GloboCare Corp. entered into a material definitive agreement. The company also provided a Regulation FD disclosure and filed financial
• Avalon GloboCare Files 8-K with Key Agreements and Equity Sales — 8-K · Jun 4, 2025 Risk: medium
  On May 29, 2025, Avalon GloboCare Corp. filed an 8-K report detailing several key events. These include entering into a material definitive agreement, unregiste
• Avalon GloboCare Corp. Files 8-K on Delisting Concerns — 8-K · May 23, 2025 Risk: high
  Avalon GloboCare Corp. filed an 8-K on May 23, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, and also indica
• Avalon GloboCare Files Q1 2025 10-Q Report — 10-Q · May 13, 2025 Risk: low
  Avalon GloboCare Corp. filed its quarterly report on Form 10-Q for the period ending March 31, 2025. The company, incorporated in Delaware, is involved in compu
• Avalon GloboCare Corp. Files 8-K with Exhibits — 8-K · Apr 29, 2025 Risk: low
  On April 29, 2025, Avalon GloboCare Corp. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update rath
• Avalon GloboCare Files 8-K: Regulation FD & Exhibits — 8-K · Apr 15, 2025 Risk: low
  On April 15, 2025, Avalon GloboCare Corp. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the inclusion of Financial Statements
• Avalon GloboCare Corp. Files 8-K Report — 8-K · Apr 10, 2025 Risk: low
  On April 10, 2025, Avalon GloboCare Corp. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the submission of Financial Statements
• Avalon GloboCare Corp. Files 8-K — 8-K · Apr 1, 2025 Risk: low
  Avalon GloboCare Corp. filed an 8-K on April 1, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, incorporated in D
• Avalon GloboCare Files 2024 Annual Report — 10-K · Mar 31, 2025 Risk: medium
  Avalon GloboCare Corp. filed its 10-K for the fiscal year ended December 31, 2024. The company, incorporated in Delaware and headquartered in Freehold, NJ, oper
• Avalon GloboCare Corp. Files 8-K with Material Agreements — 8-K · Mar 10, 2025 Risk: medium
  On March 7, 2025, Avalon GloboCare Corp. entered into a material definitive agreement. The company also amended its articles of incorporation or bylaws and repo
• Avalon GloboCare Corp. Files 8-K for Material Agreement — 8-K · Feb 27, 2025 Risk: medium
  On February 26, 2025, Avalon GloboCare Corp. entered into a Material Definitive Agreement. The company, incorporated in Delaware with its principal executive of
• Avalon GloboCare Corp. Files 8-K — 8-K · Feb 18, 2025 Risk: low
  Avalon GloboCare Corp. filed an 8-K on February 18, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contai
• Avalon GloboCare Corp. Files 8-K with Key Corporate Updates — 8-K · Jan 10, 2025 Risk: medium
  Avalon GloboCare Corp. filed an 8-K on January 10, 2025, reporting on several key events. These include entering into a material definitive agreement, unregiste
• Avalon GloboCare Corp. Files 8-K: Material Agreement & Equity Sales — 8-K · Dec 26, 2024 Risk: medium
  On December 19, 2024, Avalon GloboCare Corp. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities
• Avalon GloboCare Corp. Files 8-K — 8-K · Dec 19, 2024 Risk: low
  On December 13, 2024, Avalon GloboCare Corp. (ALBT) filed an 8-K report. The filing indicates that the company's common stock is traded on The Nasdaq Capital Ma
• Avalon GloboCare Corp. Files 8-K — 8-K · Nov 21, 2024 Risk: low
  On November 19, 2024, Avalon GloboCare Corp. filed an 8-K report. The filing indicates that the company is a biological products company, not involved in diagno
• Avalon GloboCare Files 8-K — 8-K · Nov 18, 2024 Risk: low
  Avalon GloboCare Corp. filed an 8-K on November 18, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contai
• Avalon GloboCare Files Q3 2024 10-Q — 10-Q · Nov 12, 2024 Risk: medium
  Avalon GloboCare Corp. filed its 10-Q for the quarterly period ended September 30, 2024. The company, incorporated in Delaware, operates in the biological produ
• Avalon GloboCare Faces Delisting Notice — 8-K · Nov 1, 2024 Risk: high
  Avalon GloboCare Corp. filed an 8-K on November 1, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard as of Octobe
• Avalon GloboCare Corp. Files 8-K — 8-K · Oct 31, 2024 Risk: low
  Avalon GloboCare Corp. filed an 8-K on October 31, 2024, to report on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not cont
• Avalon GloboCare Changes Fiscal Year End — 8-K · Oct 29, 2024 Risk: low
  Avalon GloboCare Corp. filed an 8-K on October 23, 2024, reporting a change in its fiscal year end to December 31st. This filing also includes financial stateme
• Avalon GloboCare Corp. Files 8-K Report — 8-K · Oct 25, 2024 Risk: low
  On October 25, 2024, Avalon GloboCare Corp. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. N
• Avalon GloboCare Files 8-K — 8-K · Oct 24, 2024 Risk: low
  Avalon GloboCare Corp. filed an 8-K on October 24, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain
• Avalon GloboCare Corp. Files 8-K on Shareholder Matters — 8-K · Oct 11, 2024 Risk: low
  Avalon GloboCare Corp. filed an 8-K on October 11, 2024, reporting on matters submitted to a vote of its security holders as of October 7, 2024. The filing deta
• Avalon GloboCare Corp. Files 8-K Report — 8-K · Oct 9, 2024 Risk: low
  On October 9, 2024, Avalon GloboCare Corp. filed an 8-K report. The filing primarily concerns financial statements and exhibits, as well as a Regulation FD disc
• Avalon GloboCare Files Proxy Statement for Oct. 7 Meeting — DEF 14A · Aug 28, 2024 Risk: medium
  Avalon GloboCare Corp. filed a DEF 14A proxy statement on August 28, 2024, for its annual meeting on October 7, 2024. The company, previously known as Global Te
• Avalon GloboCare Files Q2 2024 10-Q — 10-Q · Aug 19, 2024 Risk: low
  Avalon GloboCare Corp. filed its 10-Q for the quarterly period ended June 30, 2024. The company, incorporated in Delaware, operates in the Biological Products s
• Avalon GloboCare Files 8-K — 8-K · Aug 14, 2024 Risk: medium
  Avalon GloboCare Corp. filed an 8-K on August 14, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain
• Avalon GloboCare Corp. Files 8-K Report — 8-K · Jul 31, 2024 Risk: low
  On July 31, 2024, Avalon GloboCare Corp. filed an 8-K report. The filing primarily concerns financial statements and exhibits, as well as a Regulation FD disclo
• Avalon GloboCare Corp. Files 8-K Report — 8-K · Jul 18, 2024 Risk: low
  On July 18, 2024, Avalon GloboCare Corp. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No s

Related Companies

AVLO · AVCO

Frequently Asked Questions